Economic impact of patients admitted to stroke units in Spain

Jose Alvarez-Sabín (), Manuel Quintana, Jaime Masjuan, Juan Oliva (), Javier Mar, Nuria Gonzalez-Rojas, Virginia Becerra, Covadonga Torres and María Yebenes
Additional contact information
Jose Alvarez-Sabín: Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona
Manuel Quintana: Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona
Jaime Masjuan: Hospital Universitario Ramón y Cajal, Universidad de Alcalá
Javier Mar: Hospital Alto Deba
Nuria Gonzalez-Rojas: Boehringer Ingelheim España
Virginia Becerra: Boehringer Ingelheim España
Covadonga Torres: Pharmacoeconomics and Outcomes Research Iberia
María Yebenes: Pharmacoeconomics and Outcomes Research Iberia

The European Journal of Health Economics, 2017, vol. 18, issue 4, No 5, 449-458

Abstract: Abstract Objectives Stroke is a major social and health problem. However, since the recent incorporation of new advances in its management, little is known about the cost of stroke. The aim of this study is to find out the real cost of stroke in Spain. Methods This is an epidemiological, observational, prospective, multicenter study of patients diagnosed with stroke and admitted to a stroke unit. Patients were recruited from 16 hospitals throughout Spain and followed up for 1 year. Sociodemographic, clinical, and economic data were collected. Costs (€ 2012) were estimated from the social perspective and were divided into direct healthcare (inpatient, outpatient, and medication), direct non-healthcare (mainly formal and informal care) and labor productivity losses. Results A total of 321 patients were included. Mean age was 72.1 years and 176 patients (54.8 %) were male. Total average cost per patient/year was €27,711. Direct healthcare costs amounted to €8491 per patient/year (68.8 % due to inpatient costs) and non-healthcare costs to an average of €18,643 per patient/year (89.5 % due to informal care). Productivity loss costs per patient/year were €276. Total costs of hemorrhagic strokes were slightly higher than ischemic (€28,895 vs. €27,569 per patient/year, p = 0.550) without significant differences. The main variables associated with higher costs were the presence of hypertension (€30,332 vs. €23,234 per patient/year, p

Keywords: Cost of illness; Economic impact; Healthcare and non-healthcare costs; Social perspective; Stroke (search for similar items in EconPapers)
JEL-codes: I1 J14 (search for similar items in EconPapers)
Date: 2017
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (3)

Downloads: (external link)
http://link.springer.com/10.1007/s10198-016-0799-9 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:eujhec:v:18:y:2017:i:4:d:10.1007_s10198-016-0799-9

Ordering information: This journal article can be ordered from
http://www.springer. ... cs/journal/10198/PS2

DOI: 10.1007/s10198-016-0799-9

Access Statistics for this article

The European Journal of Health Economics is currently edited by J.-M.G.v.d. Schulenburg

More articles in The European Journal of Health Economics from Springer, Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ) Contact information at EDIRC.
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().